Form D · Venture Capital Fund
MDC - Verte Fund, LLC
Baltimore, MD · CIK 0001880432
Offering snapshot reported Mar 4, 2025 · SEC filing
- Reported sold
- $1.03M Indefinite offering
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Jul 26, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$606,000 → $1,027,000
- Reported investors8 → 10
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2025 | Amendment | $1,027,000 | $421,000vs Feb 5, 2024 | 10 | SEC filing |
| Feb 5, 2024 | Amendment | $606,000 | $600,000vs Aug 26, 2021 | 8 | SEC filing |
| Aug 26, 2021 | Initial | $6,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-411435
Source: Form D, filed Mar 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
MDC - VERTE FUND, LLC
Investment adviser: PI ANALYTICS, LLC
- Gross asset value
- $606K
- Beneficial owners
- 8
- ADV minimum commitment
- $2K
Reported in Form ADV on Feb 14, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Filing source
Form ADV 1826423 · Feb 14, 2024 · Schedule D 7.B.(1), fund 805-5027538969
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gil Blankenship | Director |
| Leonard Mills | Director |
| Jonathan Pearl | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Baltimore, MD, 21201